Issue 5/1997
Content (7 Articles)
ORIGINAL ARTICLE
Variant mouse lymphoma cells with modified response to interferon demonstrate enhanced immunogenicity
N. Mador, Haya Falk, Michael Bergel, Amos Panet, J. Hochman
ORIGINAL ARTICLE
Efficiency of T cell triggering by anti-CD3 monoclonal antibodies (mAb) with potential usefulness in bispecific mAb generation
Nathalie Jacobs, Alessandra Mazzoni, Delia Mezzanzanica, Donatella R. M. Negri, Olga Valota, Maria I. Colnaghi, Michel P. Moutschen, Jacques Boniver, Silvana Canevari
ORIGINAL ARTICLE
Induction of multiple anti-c-erbB-2 specificities accompanies a classical idiotypic cascade following 2B1 bispecific monoclonal antibody treatment
J. I. Clark, R. Katherine Alpaugh, Margaret von Mehren, Josephine Schultz, Julie R. Gralow, Martin A. Cheever, David B. Ring, L. M. Weiner
ORIGINAL ARTICLE
Gene transfer of a hybrid interleukin-1β gene to B16 mouse melanoma recruits leucocyte subsets and reduces tumour growth in vivo
Olle Björkdahl, Anette Gjörloff Wingren, Gunnar Hedlund, Lennart Ohlsson, M. Dohlsten
ORIGINAL ARTICLE
The participation of the Fas-mediated cytotoxic pathway by natural killer cells is tumor-cell-dependent
Shunsuke Mori, Anahid Jewett, Kaoru Murakami-Mori, Marta Cavalcanti, B. Bonavida
ORIGINAL ARTICLE
Interleukin-4 is effective in restoring cytotoxic T cell activity that declines during in vivo progression of a murine B lymphoma
Sampa Santra, S. K. Ghosh
ORIGINAL ARTICLE
Tunnelled central venous catheters yield a low incidence of septicaemia in interleukin-2-treated patients
S. H. Goey, J. Verweij, R. L. H. Bolhuis, D. de Gooyer, A. M. M. Eggermont, P. I. M. Schmitz, G. Stoter